Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3490-3494

  Yang, Jin Ming ^a   Chin, Khew Voon ^a   Hait, William N ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; ISOENZYME; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

BREAST NEOPLASMS; CARCINOMA; DRUG RESISTANCE, MULTIPLE; HUMANS; ISOENZYMES; P-GLYCOPROTEIN; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN KINASE C; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0029683163     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Endicott, J. A., and Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171, 1989.
2. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter Annu. Rev. Biochem., 62: 385-427, 1993.
3. Ford, J. M., and Hait, W. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev., 42: 155-199, 1990.
4. Chen, C-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., and Roninson, I. B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell, 47: 381-389, 1986.
5. Gros, P., Croop, J., and Housman, D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell, 47: 371-380, 1986.
6. Cornwell, M. M., Tsuruo, T., Gottesman, M. M., and Pastan, I. ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. FASEB J., 1: 51-54, 1987.
7. r 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res., 48: 4926-4932, 1988.
8. Cornwell, M. M., Gottesman, M. M., and Pastan, I. Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells J. Biol. Chem., 261: 7921-7928, 1986.
9. Kamimoto, Y., Gatmaitan, J., Hsu, J., and Arias, I. M. The function of Gp 170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J. Biol. Chem., 264: 11693-11698, 1989.
10. Cornwell, M. M., Pastan, I., and Gottesman, M. M. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J. Biol. Chem., 262: 2166-2170, 1987.
11. Foxwell, B. M. J., Mackie, A., Ling, V., and Ryffel, B. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol. Pharmacol., 36: 543-546, 1989.
12. Carlsen, S. A., Till, J. E., and Ling, V. Modulation of drug permeability in Chinese hamster ovary cells: possible role for phosphorylation of surface glycoproteins. Biochim. Biophys. Acta, 467: 238-250, 1977.
13. r 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil, trifluoperazine, and phorbol esters. Cancer Res., 47: 2860-2865, 1987.
14. Chambers, T. C., McAvoy, E. M., Jacobs, J. W., and Eilon, G. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J. Biol. Chem., 265: 7679-7686, 1990.
15. Yu, G., Ahmad, S., Auino, A., Fairchild, C. R., Trepel, J. B., Ohno, S., Suzuki, K., Tsuruo, T., Cowan, K. H., and Glazer, R. I. Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun., 3: 181-189, 1991.
16. Schurr, E., Raymond, M., Bell, J. C., and Gros, P. Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA. Cancer Res., 49: 2729-2734, 1989.
17. Germann, U. A., Chambers, T. C., Ambudkar, S. V., Pastan, I., and Gottesman, M. M. Effects of phosphorylation of P-glycoprotein on multidrug resistance. J. Bioenerg. Biomembr., 27: 53-61, 1995.
18. Palayoor, S. T., Stein, J. M., and Hait, W. N. Inhibition of protein kinase C by antineoplastic agents, implications for drug resistance. Biochem. Biophys. Res. Commun., 148: 718-725, 1987.
19. Posada, J. A., McKeegan, E. M., Worthington, K. F., Morin, M. J., Jaken, S., and Tritton, T. R. Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance Cancer Commun., 1: 285-292, 1989.
20. Posada, J., Vichi, P., and Tritton, T. R. Protein kinase C in Adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res., 49: 6634-6639, 1989.
21. Gollapudi, S., Patel, K., and Gupta, S. Protein kinase C isoforms in multidrug resistant P388/ADR cells: a possible role in daunorubicin transport. Cancer Lett., 62: 69-75, 1992.
22. Blobe, G. C., Sachs, C. W., Khan, W. A., Fabbro, D., Stable, S., Wetsel, W. C., Obeid, L. M., Fine, R. L., and Hannun, Y. A. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. J. Biol. Chem., 268: 658-664, 1993.
23. Drew, L., Warr, J. R., and Rumsby, M. G. A role for protein kinase C in the multidrug resistance phenotype of human carcinoma KB cell lines. Biochem. Soc. Transact., 23: 447S, 1995.
24. Fenton, J. A. L., Warr, J. R., and Rumsby, M. G. The relationship between protein kinase C subspecies and multidrug resistance in vincristine resistant Chinese hamster ovary cells. Biochem. Soc. Transact., 23: 450S, 1995.
25. Aftab, D. T., Yang, J. M., and Hait, W. N. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells. Oncol. Res., 6: 59-70, 1994.
26. Chambers, T. C., Chalikonda, I., and Eilon, G. Correlation of protein kinase C translocation, P-glycoprotem phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem. Biophys. Res. Commun., 169: 253-259, 1990.
27. Fine, R. L., Patel, J., and Chabner, B. A. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl. Acad. Sci. USA, 85: 582-586, 1988.
28. Chambers, T. C., Zheng, B., and Kuo, J. F. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells Mol. Pharmacol., 41: 1008-1015, 1992.
29. Aftab, D. T., Ballas, L. M., Loomis, C. R., and Hait, W. N. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C: Identification of potent and selective inhibitors. Mol. Pharmacol., 40: 798-805, 1991.
30. Mori, T., Takai, Y., Minakuchi, R., Yu, B., and Nishizuka, Y. Inhibitory action of chlorpromazine, dibucaine, and other phosphotipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. J. Biol. Chem., 255: 8378-8380, 1980.
31. Schatzman, R. C., Wise, B. C., and Kuo, J. F. Phospholipid-sensitive calcium-dependent protein kinase: inhibition by anti-psychotic drugs Biochem. Biophys. Res. Commun., 98: 669-676, 1981.
32. O'Brian, C. A., Liskamp, R. M., Solomon, D. H., and Weinstein, I. B. Inhibition of protein kinase C by tamoxifen. Cancer Res., 45: 2462-2465, 1985.
33. Walker, R. J., Lazzaro, V. A., Duggin, G. G., Horvath, J. S., and Tiller, D. J. Cyclosporin A inhibits protein kinase C activity: a contributing mechanism in the development of nephrotoxicity. Biochem. Biophys. Res. Commun., 160: 409-415, 1989.
34. Ahmad, S., Trepel, J. B., Ohno, S., Suzuki, K., Tsuruo, T., and Glazer, R. I. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical γ isoform of protein kinase C does not confer increased resistance to doxorubicin. Mol. Pharmacol., 42: 1004-1009, 1992.
35. Ahmad, S., Safa, A. R., and Glazer, R. I. Modulation of P-glycoprotein by protein kinase Cα in a baculovirus expression system. Biochemistry, 33: 10313-10318, 1994.
36. Chambers, T. C., Pohl, J., Raynor, R. L., and Kuo, J. F. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J. Biol. Chem., 268: 4592-4595, 1993.
37. Orr, G. A., Han, E. K-H., Browne, P. C., Nieves, E., O'Connor, B. M., Yang, C-P., and Horwitz, S. B. Identification of the major phosphorylation domain of murine mdrIb P-glycoprotein. J. Biol. Chem. 268: 25054-25062, 1993.
38. Parker, P. J. Protein Kinases, pp. 68-84. In: J. R. Woodgett (ed.). Protein kinase C and its relatives. New York. Oxford University Press, 1994.
39. Gordge, P. C., and Ryves, W. J Inhibitors of protein kinase C. Cell. Signal, 6: 871-882, 1994.
40. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
41. Chambers, T. C. Expression and subcellular distribution of protein kinase C isoforms in multidrug-resistant KB cells. Proc. Am. Assoc. Cancer Res., 36: 338, 1995.
42. Hyatt, S. L., Liao, L., Aderem, A., Nairn, A. C., and Jaken, S. Correlation between protein kinase C binding proteins and substrates in REF52 cells. Cell Growth & Differ., 5: 495-502, 1994.
43. Gescher, A., Budworth, J., and Gant, T. W. Co-regulation of multidrug resistance (MDR) phenotype and protein kinase (PKC) expression in MCF-7/Adr cells. Proc. Am. Assoc. Cancer Res., 37: 308, 1996.
44. Nishizuka, Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington DC), 258: 607-614, 1992.
45. Hug, H., and Sarre, T. F. Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J., 291: 329-343, 1993.
46. Mochly-Rosen, D. Localization of protein kinase by anchoring proteins a theme in signal transduction Science (Washington DC), 268: 247-251, 1995.
47. Yang, J. M., Chin, K. V., and Hait, W. N. Involvement of phospholipase C in heat-shock induced phosphorylation of P-glycoprotein in multidrug resistant human breast cancer cells. Biochem. Biophys. Res. Commun., 210: 21-30, 1995.
48. Yang, J. M., and Hait, W. N. Regulation of the function of P-glycoprotein by epidermal growth factor through phospholipase C. Proc. Am. Assoc. Cancer Res., 36: 333, 1995.
49. Posada, J., Vichi, P., and Tritton, T. R. Protein kinase C in Adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res., 49: 6634-6639, 1989.